Latest GMED Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| David Saxon | Needham | Upgrades | Strong Buy | $112.00 | |
| Caitlin Cronin | Canaccord Genuity | Maintains | Strong Buy | $105.00 → $112.00 +7.00 (6.7%) | |
| Matt O'Brien | Piper Sandler | Reiterates | Buy | $90.00 → $115.00 +25.00 (27.8%) | |
| Caitlin Cronin | Canaccord Genuity | Maintains | Strong Buy | $90.00 → $105.00 +15.00 (16.7%) | |
| Keith Hinton | Freedom Capital | Initiates | Hold | $87.00 | |
| Shagun Singh | RBC Capital | Maintains | Buy | $92.00 → $100.00 +8.00 (8.7%) | |
| Drew Ranieri | Morgan Stanley | Maintains | Buy | $70.00 → $100.00 +30.00 (42.9%) |
David Saxon
Needham
Strong BuyUpgrades
$112.00
Caitlin Cronin
Canaccord Genuity
Strong BuyMaintains
$105.00 → $112.00
Matt O'Brien
Piper Sandler
BuyReiterates
$90.00 → $115.00
Caitlin Cronin
Canaccord Genuity
Strong BuyMaintains
$90.00 → $105.00
Keith Hinton
Freedom Capital
HoldInitiates
$87.00
Shagun Singh
RBC Capital
BuyMaintains
$92.00 → $100.00
Drew Ranieri
Morgan Stanley
BuyMaintains
$70.00 → $100.00